RxDoctor Payments Data

Daniel Oakes, MD

Adult Reconstructive Orthopaedic Surgery · Los Angeles, CANPI 1174636302

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $205,405 of the $296,200 with a category attached, or 69.3%. 9 manufacturers reported payments, led by Limacorporate S.p.a. at 59.2% of the total.

$296,200in general payments, 2019–2025

Across 133 payments — averaging $2227.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Limacorporate S.p.a.$175K
  • Encore Medical, LP$102K
  • Lima USA, Inc.$15K
  • Medical Device Business Services, Inc.$2K
  • Zimmer Biomet$1K
  • Stryker$562
  • plus $138 from 3 others

What the payments were for

  • Royalty or licence$10,9124%
  • Consulting fees$205,40569%
  • Travel & lodging$76,77526%
  • Food & beverage$3,1081%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$296,200 in reported general payments places this provider in the 85th percentile of 136 adult reconstructive orthopaedic surgery providers in California.

See all adult reconstructive orthopaedic surgery providers in California

Medicare billing

Part B allowed, 2024
$429,761
Medicare patients
850
Services billed
1,633

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin13$114
Amoxicillin21$51
Tramadol Hcl11$30

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →